Your browser is no longer supported. Please, upgrade your browser.
Settings
HAE [NYSE]
Haemonetics Corporation
Index- P/E28.92 EPS (ttm)2.11 Insider Own0.50% Shs Outstand50.79M Perf Week-9.25%
Market Cap3.12B Forward P/E17.40 EPS next Y3.51 Insider Trans-9.18% Shs Float50.52M Perf Month-46.35%
Income108.10M PEG2.89 EPS next Q0.67 Inst Own- Short Float3.87% Perf Quarter-56.16%
Sales883.90M P/S3.53 EPS this Y42.10% Inst Trans1.60% Short Ratio2.76 Perf Half Y-35.95%
Book/sh14.16 P/B4.31 EPS next Y36.87% ROA8.00% Target Price- Perf Year-41.12%
Cash/sh3.70 P/C16.52 EPS next 5Y10.00% ROE16.70% 52W Range60.68 - 142.11 Perf YTD-48.60%
Dividend- P/FCF26.55 EPS past 5Y35.40% ROI9.60% 52W High-57.05% Beta0.35
Dividend %- Quick Ratio1.90 Sales past 5Y1.70% Gross Margin48.60% 52W Low0.59% ATR3.61
Employees3004 Current Ratio3.40 Sales Q/Q-7.20% Oper. Margin15.50% RSI (14)16.12 Volatility3.45% 4.40%
OptionableYes Debt/Eq0.43 EPS Q/Q7.20% Profit Margin12.20% Rel Volume1.05 Prev Close61.44
ShortableYes LT Debt/Eq0.41 EarningsMay 13 BMO Payout0.00% Avg Volume708.21K Price61.04
Recom2.00 SMA20-25.56% SMA50-41.03% SMA200-41.79% Volume741,940 Change-0.65%
Apr-20-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21Upgrade Barrington Research Mkt Perform → Outperform $140
Jan-21-21Downgrade Barrington Research Outperform → Mkt Perform
Nov-05-20Upgrade Barrington Research Mkt Perform → Outperform $106
May-06-20Downgrade Barrington Research Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Jan-10-20Initiated Needham Buy $138
Aug-07-19Reiterated Barrington Research Outperform $116 → $139
May-14-19Upgrade Raymond James Mkt Perform → Outperform $110
May-08-19Reiterated Barrington Research Outperform $112 → $116
Aug-09-18Reiterated Barrington Research Outperform $90 → $118
Feb-07-18Reiterated Barrington Research Outperform $57 → $71
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-08-17Reiterated Barrington Research Outperform $48 → $57
Aug-08-17Upgrade Barrington Research Mkt Perform → Outperform $48
Jul-13-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Feb-07-17Downgrade Barrington Research Outperform → Mkt Perform
Nov-08-16Upgrade Barrington Research Mkt Perform → Outperform $41
Nov-07-16Reiterated The Benchmark Company Hold $32 → $34
May-06-21 03:00PM  
May-03-21 10:39AM  
Apr-29-21 06:45AM  
Apr-26-21 11:56AM  
10:14AM  
Apr-23-21 04:05PM  
Apr-19-21 07:47AM  
06:00AM  
Apr-06-21 05:19AM  
Mar-24-21 09:59AM  
Mar-07-21 03:09AM  
Mar-04-21 11:30AM  
Mar-02-21 08:21PM  
Mar-01-21 04:05PM  
Feb-26-21 06:50AM  
Feb-04-21 11:59PM  
Feb-03-21 08:16AM  
Feb-02-21 04:30PM  
07:30AM  
07:09AM  
06:00AM  
05:45AM  
Feb-01-21 10:55AM  
Jan-26-21 12:31PM  
12:12PM  
Jan-22-21 09:50AM  
06:45AM  
Jan-20-21 06:45AM  
Jan-18-21 10:05AM  
Jan-05-21 05:03PM  
Dec-21-20 04:13PM  
Dec-04-20 11:31AM  
Dec-01-20 10:52AM  
Nov-06-20 02:28PM  
Nov-05-20 10:34AM  
08:44AM  
Nov-04-20 07:30AM  
07:11AM  
06:15AM  
06:00AM  
Oct-28-20 12:32PM  
Oct-06-20 04:15PM  
Oct-02-20 08:36PM  
Sep-09-20 04:53PM  
Sep-08-20 08:08PM  
Sep-03-20 11:31AM  
Aug-07-20 06:45AM  
Aug-05-20 09:52AM  
07:37AM  
Aug-04-20 07:30AM  
07:28AM  
06:00AM  
Jul-28-20 12:32PM  
Jul-24-20 06:45AM  
Jul-22-20 05:57PM  
Jul-09-20 08:53PM  
Jul-06-20 04:15PM  
Jun-30-20 04:15PM  
Jun-08-20 10:08AM  
Jun-05-20 09:47AM  
Jun-03-20 06:45AM  
01:10AM  
May-28-20 04:18PM  
May-26-20 12:39AM  
May-11-20 08:03AM  
May-06-20 11:33AM  
May-05-20 09:01PM  
May-04-20 04:41PM  
01:36PM  
11:02AM  
09:08AM  
Apr-28-20 12:33PM  
Apr-24-20 09:05AM  
Apr-17-20 01:13PM  
Apr-16-20 12:10PM  
Apr-06-20 09:09AM  
Apr-03-20 08:00AM  
Apr-02-20 06:45AM  
Mar-30-20 04:15PM  
12:00PM  
Mar-26-20 04:52PM  
Mar-18-20 06:47AM  
Mar-09-20 09:20AM  
Mar-05-20 11:30AM  
Mar-03-20 09:22AM  
Mar-02-20 10:42AM  
Feb-18-20 08:52AM  
Feb-11-20 07:59AM  
Feb-07-20 11:30AM  
Feb-06-20 09:58PM  
Feb-05-20 10:51AM  
Feb-04-20 07:30AM  
06:00AM  
Feb-03-20 10:58AM  
Jan-28-20 12:31PM  
Jan-27-20 04:46PM  
Jan-23-20 10:48AM  
09:01AM  
Jan-22-20 10:44AM  
10:07AM  
Haemonetics Corporation, a healthcare company, provides hematology products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lingamneni AnilaEVP, Chief Technology OfficerApr 16Sale119.4417020,3053,444Apr 20 04:20 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 08Sale120.0710712,8474,380Mar 10 04:11 PM
Basil Michelle LEVP and General CounselMar 08Sale120.0738546,22715,607Mar 10 04:08 PM
MEELIA RICHARD JDirectorFeb 04Option Exercise35.5010,353367,55742,403Feb 05 04:51 PM
Goldstein DanVP, Corporate ControllerFeb 04Option Exercise58.932,433143,3723,206Feb 05 04:36 PM
Dockendorff Charles JDirectorFeb 04Option Exercise35.5012,180432,42025,935Feb 05 04:46 PM
Goldstein DanVP, Corporate ControllerFeb 04Sale135.862,671362,8881,511Feb 05 04:36 PM
Dockendorff Charles JDirectorFeb 04Sale134.5312,1801,638,57513,755Feb 05 04:46 PM
MEELIA RICHARD JDirectorFeb 04Sale134.6410,3531,393,92832,050Feb 05 04:51 PM
Goldstein DanVP, Corporate ControllerOct 26Sale106.0010010,6001,749Oct 28 05:02 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 26Sale106.001,161123,06611,337Oct 28 04:59 PM
Basil Michelle LEVP and General CounselOct 23Sale106.5818119,29115,992Oct 26 04:55 PM
Llorens JosepSVP, Global ManufacturingSep 08Sale88.711018,9604,254Sep 10 05:04 PM
ABERNATHY ROBERT EDirectorAug 11Buy80.934,000323,72012,048Aug 12 06:04 PM
Simon, ChristopherPresident & CEOJun 30Sale87.795,084446,324365,310Jul 02 04:20 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 16Sale91.0212,6141,148,16212,498Jun 16 06:16 PM
Basil Michelle LEVP and General CounselJun 16Sale91.0213,4361,223,00616,173Jun 16 06:19 PM
Goldstein DanVP, Corporate ControllerJun 16Sale91.533,040278,2511,849Jun 16 05:55 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 16Sale91.536,869628,7204,487Jun 16 05:53 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 15Option Exercise41.642,889120,29815,361Jun 16 05:53 PM
Basil Michelle LEVP and General CounselJun 15Sale87.7110,578927,79629,609Jun 16 06:19 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 15Sale87.719,720852,54125,112Jun 16 06:16 PM
Simon, ChristopherPresident & CEOJun 15Sale87.7145,7234,010,364370,394Jun 16 05:51 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 15Sale88.808,422747,86511,356Jun 16 05:53 PM
Goldstein DanVP, Corporate ControllerJun 15Sale87.671,374120,4634,889Jun 16 05:55 PM
Goldstein DanVP, Corporate ControllerJun 12Sale82.29423,4566,263Jun 16 05:55 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 12Sale89.291119,91116,889Jun 16 05:53 PM
Simon, ChristopherPresident & CEOJun 12Sale89.291,294115,541416,117Jun 16 05:51 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 12Sale89.2919717,59034,832Jun 16 06:16 PM
Basil Michelle LEVP and General CounselJun 12Sale89.2920318,12640,187Jun 16 06:19 PM
Goldstein DanVP, Corporate ControllerJun 09Sale97.1918718,1751,983Jun 10 06:04 PM
Goldstein DanVP, Corporate ControllerJun 08Option Exercise41.641,10646,0543,276Jun 10 06:04 PM
Goldstein DanVP, Corporate ControllerJun 08Sale98.951,189117,6472,170Jun 10 06:04 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 08Sale97.0332431,4385,714Jun 10 05:59 PM
Basil Michelle LEVP and General CounselJun 08Sale97.0368766,66016,376Jun 10 05:57 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 08Sale97.0363962,00212,695Jun 10 05:54 PM
Simon, ChristopherPresident & CEOJun 08Sale97.032,920283,328315,347Jun 10 05:52 PM
Goldstein DanVP, Corporate ControllerMay 18Sale101.7210110,2741,709May 19 06:10 PM
Simon, ChristopherPresident & CEOMay 15Sale100.441,008101,244303,757May 19 07:06 PM
Goldstein DanVP, Corporate ControllerMay 15Sale100.44424,2181,810May 19 06:10 PM
Llorens JosepSVP, Global ManufacturingMay 15Sale100.4410710,7472,663May 19 05:51 PM
Scanlan JacquelineSVP, Global Human ResourcesMay 15Sale100.4411011,0484,466May 19 05:34 PM
Basil Michelle LEVP and General CounselMay 15Sale100.4420320,38914,161May 19 05:20 PM
Burke William P. Mr.EVP, Chief Financial OfficerMay 15Sale100.4422122,19710,190May 19 05:10 PM